Concord Medical Services Net Income
| CCM Stock | USD 3.64 0.14 4.00% |
As of the 28th of February, Concord Medical shows the Risk Adjusted Performance of 0.0316, downside deviation of 5.04, and Mean Deviation of 4.1. Concord Medical Services technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Concord Medical Services jensen alpha, as well as the relationship between the potential upside and skewness to decide if Concord Medical Services is priced correctly, providing market reflects its regular price of 3.64 per share. Given that Concord Medical has jensen alpha of 0.0284, we suggest you to validate Concord Medical Services's prevailing market performance to make sure the company can sustain itself at a future point.
Concord Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 10.2626 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -277.4 M | -291.3 M | |
| Net Loss | -586.9 M | -557.5 M | |
| Net Loss | -586.9 M | -557.5 M | |
| Net Loss | -2.4 K | -2.6 K | |
| Net Income Per E B T | 0.53 | 0.50 |
Concord | Net Income | Build AI portfolio with Concord Stock |
Evaluating Concord Medical's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Concord Medical Services's fundamental strength.
Latest Concord Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Concord Medical Services over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Concord Medical Services financial statement analysis. It represents the amount of money remaining after all of Concord Medical Services operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Concord Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Concord Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (652.08 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Concord Net Income Regression Statistics
| Arithmetic Mean | (192,970,263) | |
| Coefficient Of Variation | (97.75) | |
| Mean Deviation | 152,877,096 | |
| Median | (263,547,765) | |
| Standard Deviation | 188,623,171 | |
| Sample Variance | 35578.7T | |
| Range | 614.4M | |
| R-Value | (0.72) | |
| Mean Square Error | 18077.2T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | (27,030,346) | |
| Total Sum of Squares | 569259.2T |
Concord Net Income History
Other Fundumenentals of Concord Medical Services
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Concord Medical Net Income component correlations
Concord Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Concord Medical is extremely important. It helps to project a fair market value of Concord Stock properly, considering its historical fundamentals such as Net Income. Since Concord Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Concord Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Concord Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Providers & Services sector continue expanding? Could Concord diversify its offerings? Factors like these will boost the valuation of Concord Medical. Projected growth potential of Concord fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Concord Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (5.45) | Revenue Per Share | Quarterly Revenue Growth (0.08) | Return On Assets | Return On Equity |
Understanding Concord Medical Services requires distinguishing between market price and book value, where the latter reflects Concord's accounting equity. The concept of intrinsic value - what Concord Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Concord Medical's price substantially above or below its fundamental value.
It's important to distinguish between Concord Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Concord Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Concord Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Concord Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Concord Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Concord Medical.
| 11/30/2025 |
| 02/28/2026 |
If you would invest 0.00 in Concord Medical on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding Concord Medical Services or generate 0.0% return on investment in Concord Medical over 90 days. Concord Medical is related to or competes with Longevity Health, INVO Fertility, Shineco, Scworx Corp, Celularity, and Aditxt. Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic ... More
Concord Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Concord Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Concord Medical Services upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.04 | |||
| Information Ratio | 0.014 | |||
| Maximum Drawdown | 25.36 | |||
| Value At Risk | (7.83) | |||
| Potential Upside | 12.41 |
Concord Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Concord Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Concord Medical's standard deviation. In reality, there are many statistical measures that can use Concord Medical historical prices to predict the future Concord Medical's volatility.| Risk Adjusted Performance | 0.0316 | |||
| Jensen Alpha | 0.0284 | |||
| Total Risk Alpha | (0.42) | |||
| Sortino Ratio | 0.0154 | |||
| Treynor Ratio | 0.0974 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Concord Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Concord Medical February 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0316 | |||
| Market Risk Adjusted Performance | 0.1074 | |||
| Mean Deviation | 4.1 | |||
| Semi Deviation | 4.67 | |||
| Downside Deviation | 5.04 | |||
| Coefficient Of Variation | 3326.04 | |||
| Standard Deviation | 5.58 | |||
| Variance | 31.14 | |||
| Information Ratio | 0.014 | |||
| Jensen Alpha | 0.0284 | |||
| Total Risk Alpha | (0.42) | |||
| Sortino Ratio | 0.0154 | |||
| Treynor Ratio | 0.0974 | |||
| Maximum Drawdown | 25.36 | |||
| Value At Risk | (7.83) | |||
| Potential Upside | 12.41 | |||
| Downside Variance | 25.43 | |||
| Semi Variance | 21.82 | |||
| Expected Short fall | (5.00) | |||
| Skewness | 0.4877 | |||
| Kurtosis | 0.482 |
Concord Medical Services Backtested Returns
As of now, Concord Stock is very risky. Concord Medical Services secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. We have found thirty technical indicators for Concord Medical Services, which you can use to evaluate the volatility of the firm. Please confirm Concord Medical's Risk Adjusted Performance of 0.0316, mean deviation of 4.1, and Downside Deviation of 5.04 to double-check if the risk estimate we provide is consistent with the expected return of 0.0527%. The firm shows a Beta (market volatility) of 1.62, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Concord Medical will likely underperform. Concord Medical Services right now shows a risk of 5.62%. Please confirm Concord Medical Services sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Concord Medical Services will be following its price patterns.
Auto-correlation | -0.21 |
Weak reverse predictability
Concord Medical Services has weak reverse predictability. Overlapping area represents the amount of predictability between Concord Medical time series from 30th of November 2025 to 14th of January 2026 and 14th of January 2026 to 28th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Concord Medical Services price movement. The serial correlation of -0.21 indicates that over 21.0% of current Concord Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.21 | |
| Spearman Rank Test | -0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.17 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Concord Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Concord Medical Services reported net income of (652.08 Million). This is 291.07% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is significantly higher than that of the company.
Concord Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Concord Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Concord Medical could also be used in its relative valuation, which is a method of valuing Concord Medical by comparing valuation metrics of similar companies.Concord Medical is currently under evaluation in net income category among its peers.
Concord Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Concord Medical from analyzing Concord Medical's financial statements. These drivers represent accounts that assess Concord Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Concord Medical's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 6.1M | 16.5M | 11.9M | 5.7M | 6.6M | 6.2M | |
| Enterprise Value | 2.6B | 3.1B | 3.2B | 3.7B | 3.3B | 3.5B |
Concord Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Concord Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Concord Medical's managers, analysts, and investors.Environmental | Governance | Social |
Concord Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Concord Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Concord Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Concord Medical's value.| Shares | Ubs Group Ag | 2025-06-30 | 67.9 K | Rhumbline Advisers | 2025-06-30 | 258 | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 100.0 | Sbi Securities Co Ltd | 2025-06-30 | 4.0 |
Concord Fundamentals
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.0448 | ||||
| Profit Margin | (0.45) % | ||||
| Operating Margin | (0.72) % | ||||
| Current Valuation | 545.18 M | ||||
| Shares Outstanding | 2.82 M | ||||
| Shares Owned By Insiders | 17.99 % | ||||
| Shares Owned By Institutions | 0.04 % | ||||
| Number Of Shares Shorted | 1.75 K | ||||
| Price To Earning | (3.90) X | ||||
| Price To Book | 3.00 X | ||||
| Price To Sales | 0.04 X | ||||
| Revenue | 383.96 M | ||||
| Gross Profit | (41.85 M) | ||||
| EBITDA | (345.62 M) | ||||
| Net Income | (652.08 M) | ||||
| Cash And Equivalents | 216.22 M | ||||
| Cash Per Share | 1.72 X | ||||
| Total Debt | 3.93 B | ||||
| Debt To Equity | 1.25 % | ||||
| Current Ratio | 0.71 X | ||||
| Book Value Per Share | (74.62) X | ||||
| Cash Flow From Operations | (397.75 M) | ||||
| Short Ratio | 0.28 X | ||||
| Earnings Per Share | (5.45) X | ||||
| Target Price | 1.2 | ||||
| Number Of Employees | 595 | ||||
| Beta | -1.21 | ||||
| Market Capitalization | 15.2 M | ||||
| Total Asset | 6.73 B | ||||
| Retained Earnings | (4.37 B) | ||||
| Working Capital | (1.14 B) | ||||
| Current Asset | 1.51 B | ||||
| Current Liabilities | 1.51 B | ||||
| Net Asset | 6.73 B |
About Concord Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Will Health Care Providers & Services sector continue expanding? Could Concord diversify its offerings? Factors like these will boost the valuation of Concord Medical. Projected growth potential of Concord fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Concord Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (5.45) | Revenue Per Share | Quarterly Revenue Growth (0.08) | Return On Assets | Return On Equity |
Understanding Concord Medical Services requires distinguishing between market price and book value, where the latter reflects Concord's accounting equity. The concept of intrinsic value - what Concord Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Concord Medical's price substantially above or below its fundamental value.
It's important to distinguish between Concord Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Concord Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Concord Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.